The partnership enables hundreds of thousands of Dexcom CGM users in the U.S. to seamlessly use DreaMed’s Advisor Pro platform for optimal patient insulin therapy management
DreaMed Diabetes, the developer of personalized diabetes management solutions, and DexCom Inc., the leader in continuous glucose monitoring (CGM) for people with diabetes, announced a data partnership agreement. The collaboration enables a seamless data transfer of CGM data from Dexcom into DreaMed Advisor, an advanced decision support platform designed to assist healthcare professionals in the optimization of patient-specific insulin therapy for people with diabetes.
DreaMed Advisor is a cloud-based digital solution generating insulin delivery recommendations by analyzing information from CGM, self-monitoring blood glucose (SMBG) and insulin delivery devices. Its current version, DreaMed Advisor Pro, applies event-driven adaptive learning to refine its understanding for each individual. The solution sends recommendations to healthcare providers on how to optimize patient insulin pump settings for basal rate, carbohydrate ratio (CR) and correction factor (CF). The NextDREAM consortium has recently completed a multicenter, multinational, randomized controlled study with 108 subjects to evaluate DreaMed Advisor Pro in comparison to experts from the NextDREAM consortium.
“DreaMed Diabetes’ mission is to supply people with diabetes and healthcare professionals with a reliable, automated decision-support tool that empowers every patient to receive the best care,” says Eran Atlas, CEO of DreaMed Diabetes. “We are excited to be working with an industry leader like Dexcom. By cooperating, we can increase accessibility of the DreaMed Advisor to people using Dexcom CGM devices and allow their caregivers to provide true patient-centered care.”
“We launched our retrospective API to make Dexcom CGM data available to the global community of pioneering software developers and engineers,” said Annika Jimenez, senior vice president of software and data solutions at Dexcom. “DreaMed’s Advisor platform, integrated with Dexcom CGM data, is a perfect example of the opportunity created by our API, as well as the innovative new treatment and management solutions it brings to people with diabetes.”
Source: Company Press Release